| mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
2e-07 |
| mRNA |
CHM-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
2e-07 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
2e-07 |
| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
8e-07 |
| mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
4e-06 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
5e-06 |
| mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
9e-06 |
| mRNA |
SNX-2112 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
1e-05 |
| mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
2e-05 |
| mRNA |
rigosertib |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
2e-05 |